1. Home
  2. TVTX vs NATL Comparison

TVTX vs NATL Comparison

Compare TVTX & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$27.58

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$43.74

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
NATL
Founded
N/A
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
TVTX
NATL
Price
$27.58
$43.74
Analyst Decision
Strong Buy
Hold
Analyst Count
13
4
Target Price
$36.25
$45.60
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
92.89
73.98
EPS
N/A
2.14
Revenue
N/A
$4,354,000,000.00
Revenue This Year
$44.62
$6.13
Revenue Next Year
$31.76
$4.24
P/E Ratio
N/A
$20.40
Revenue Growth
N/A
0.86
52 Week Low
$12.91
$22.30
52 Week High
$42.13
$48.50

Technical Indicators

Market Signals
Indicator
TVTX
NATL
Relative Strength Index (RSI) 45.44 52.82
Support Level $26.72 $37.97
Resistance Level $31.47 $48.50
Average True Range (ATR) 1.09 0.90
MACD 0.03 -0.34
Stochastic Oscillator 42.49 36.50

Price Performance

Historical Comparison
TVTX
NATL

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: